Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic
Neuro-Oncology · 2023
DOI: 10.1093/neuonc/noad019 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Michael T C Poon und 21 weiteren Autor:innen. Beteiligte Einrichtung: Usher Institute, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: COVID-19, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Trust, Yorkshire Cancer Research, National Institute for Health Research.
Abstract (Originalsprache)
Background
This study assessed the international variation in surgical neuro-oncology practice and 30-day outcomes of patients who had surgery for an intracranial tumor during the COVID-19 pandemic.
Methods
We prospectively included adults aged ≥18 years who underwent surgery for a malignant or benign intracranial tumor across 55 international hospitals from 26 countries. Each participating hospital recorded cases for 3 consecutive months from the start of the pandemic. We categorized patients’ location by World Bank income groups (high [HIC], upper-middle [UMIC], and low- and lower-middle [LLMIC]). Main outcomes were a change from routine management, SARS-CoV-2 infection, and 30-day mortality. We used a Bayesian multilevel logistic regression stratified by hospitals and adjusted for key confounders to estimate the association between income groups and mortality.
Results
Among 1016 patients, the number of patients in each income group was 765 (75.3%) in HIC, 142 (14.0%) in UMIC, and 109 (10.7%) in LLMIC. The management of 200 (19.8%) patients changed from usual care, most commonly delayed surgery. Within 30 days after surgery, 14 (1.4%) patients had a COVID-19 diagnosis and 39 (3.8%) patients died. In the multivariable model, LLMIC was associated with increased mortality (odds ratio 2.83, 95% credible interval 1.37–5.74) compared to HIC.
Conclusions
The first wave of the pandemic had a significant impact on surgical decision-making. While the incidence of SARS-CoV-2 infection within 30 days after surgery was low, there was a disparity in mortality between countries and this warrants further examination to identify any modifiable factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Usher Institute, University of Edinburgh, Edinburgh, UK.
- Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh, UK.
- Department of Neurosurgery, John Radcliffe Hospital, Oxford, UK.
- Department of Surgery, Division of Neurosurgery, University of Cape Town, Cape Town, South Africa.
- Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
- National Hospital for Neurology and Neurosurgery, London, UK.
ORCID-Profile: Michael T C Poon, Hani J Marcus
Förderung
- Wellcome Trust
- Yorkshire Cancer Research
- National Institute for Health Research
- Cancer Research UK Brain Tumour Centre of Excellence Award
- Wellcome/EPSRC Centre
- National Institute for Health Research Global Health Research Unit
- Association of Coloproctology of Great Britain and Ireland
- Bowel and Cancer Research
Zitieren
APA
Poon, M. T. C., Piper, R. J., Thango, N., Fountain, D. M., Marcus, H. J., Lippa, L., Servadei, F., Esene, I. N., Freyschlag, C. F., Neville, I. S., Rosseau, G., Schaller, K., Demetriades, A. K., Robertson, F. C., Hutchinson, P. J., Price, S. J., Baticulon, R. E., Glasbey, J. C., Bhangu, A., …, & Writing Group of the COVIDSurg-Cancer neurosurgery investigators on behalf of the COVIDSurg Collaborative; British Neurosurgical Trainee Research Collaborative… (2023). Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad019
Vancouver
Poon MTC, Piper RJ, Thango N, Fountain DM, Marcus HJ, Lippa L, et al. Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad019
BibTeX
@article{Poon2023,
author = {Poon, Michael T C and Piper, Rory J and Thango, Nqobile and Fountain, Daniel M and Marcus, Hani J and Lippa, Laura and Servadei, Franco and Esene, Ignatius N and Freyschlag, Christian F and Neville, Iuri S and Rosseau, Gail and Schaller, Karl and Demetriades, Andreas K and Robertson, Faith C and Hutchinson, Peter J and Price, Stephen J and Baticulon, Ronnie E and Glasbey, James C and Bhangu, Aneel and Jenkinson, Michael D and Kolias, Angelos G and Writing Group of the COVIDSurg-Cancer neurosurgery investigators on behalf of the COVIDSurg Collaborative; British Neurosurgical Trainee Research Collaborative…, Writing Group of the COVIDSurg-Cancer neurosurgery investigators on behalf of the COVIDSurg Collaborative; British Neurosurgical Trainee Research Collaborative…},
title = {Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic},
journal = {Neuro-Oncology},
year = {2023},
doi = {10.1093/neuonc/noad019}
}
EUVIMED